Aclaris Therapeutis (ACRS) PT Raised to $4 at Stifel

May 8, 2026 12:28 PM

Stifel analyst Alex Thompson raised the price target on Aclaris Therapeutis (NASDAQ: ACRS) to $4.00 (from $3.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found